3 active not recruiting, 3 completed, 3 unknown, 2 not yet recruiting. 6 Phase 2, 5 Phase 1, 3 Phase 3.
Follow External Beam Radiotherapy (EBRT): new trials by email Literature Review of External Beam Radiotherapy (EBRT) trials Research Report on External Beam Radiotherapy (EBRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma Nimotuzumab, Cisplatin, External Beam Radiotherapy (EBRT) - Cervical Cancer | Phase 3 | Not yet recruiting | Biotech Pharmaceutical Co., Ltd. | 460 | 2024-04-01 | 2024-03-27 |
| Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer Envafolimab, Cisplatin, External Beam Radiotherapy (EBRT) - Locally Advanced Cervical Cancer | Phase 2 | Not yet recruiting | Chongqing University Cancer Hospital | 36 | 2023-05-01 | 2023-04-05 |
| A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer RP-3500, External Beam Radiotherapy (EBRT) - Solid Tumor, Metastatic Cancer | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 49 | 2022-09-30 | 2025-12-17 |
| A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer Sintilimab, Cisplatin, External Beam Radiotherapy (EBRT) - Uterine Cervical Neoplasms, Sintilimab | Phase 2 | Unknown | The Affiliated Hospital of Xuzhou Medical University | 20 | 2021-03-08 | 2021-12-28 |
| Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) Pembrolizumab, Carboplatin, Paclitaxel - Endometrial Neoplasms | Phase 3 | Active not recruiting | Merck Sharp & Dohme LLC | 990 | 2021-01-10 | 2026-09-18 |
| Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047) Pembrolizumab, Placebo for pembrolizumab, Cisplatin - Uterine Cervical Neoplasms | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1060 | 2020-05-12 | 2026-02-20 |
| AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy Polysiloxane Gd-Chelates based nanoparticles (AGuIX), External beam radiotherapy (EBRT), Uterovaginal brachytherapy - Gynecologic Cancer | Phase 1 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 18 | 2018-05-17 | 2021-07-07 |
| Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder Durvalumab (Cohort 1-3), External Beam Radiotherapy (EBRT), Bacillus Calmette-Guérin (BCG) - Urothelial Carcinoma, Bladder Cancer | Phase 1 / Phase 2 | Active not recruiting | Noah Hahn, M.D. | 186 | 2017-11-21 | 2026-07-15 |
| Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT) Radium-223 dichloride, Conventional or high dose radiotherapy - Prostate Carcinoma | Phase 2 | Unknown | University Hospital Freiburg | 274 | 2014-12-01 | 2016-04-27 |
| External Beam Radiotherapy for Muscle Invasive Bladder Cancer external beam radiotherapy (EBRT) - Toxicity | Phase 1 | Completed | University Hospital, Ghent | 77 | 2014-08-01 | 2022-12-27 |
| Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer P276-00, External beam radiotherapy (EBRT) - Squamous Cell Carcinoma of Head and Neck | Phase 1 / Phase 2 | Completed | Piramal Enterprises Limited | 23 | 2009-08-01 | 2012-11-22 |
Uterine Cervical Neoplasms (4) · Parkinson Disease 4, Autosomal Dominant Lewy Body (2) · Carcinoma, Transitional Cell (1) · Endometrial Neoplasms (1) · Neoplasm Metastasis (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Prostatic Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Urinary Bladder Neoplasms (1)
Merck Sharp & Dohme LLC (2) · Biotech Pharmaceutical Co., Ltd. (1) · Chongqing University Cancer Hospital (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Memorial Sloan Kettering Cancer Center (1) · Noah Hahn, M.D. (1) · Piramal Enterprises Limited (1) · The Affiliated Hospital of Xuzhou Medical University (1) · University Hospital Freiburg (1) · University Hospital, Ghent (1)
China (4) · United States (4) · Belgium (3) · France (3) · Germany (3) · Austria (2) · Canada (2) · Chile (2) · Colombia (2) · Czechia (2) · Greece (2) · Israel (2) · Italy (2) · Japan (2) · Norway (2)
Balaji Shewalkar, MD, DNB (1) · Dapeng Li (1) · Dehua Wu (1) · Dihong Tang (1) · Dong Qian (1) · Guang Li (1) · Guoqing Wang (1) · Hao Yang (1) · Hong Zhu (1) · Hongyun Shi (1) · Hui Qiu (1) · Huijun Cheng (1) · Jiayi Chen (1)
PMID 37084803, PMID 38521086, PMID 39284383, PMID 39288779, PMID 39411812, PMID 40592026, PMID 41514314
2016 (1), 2019 (1)